62257-16-3

Basic information

• Product Name: 3-Amino-4-fluorophenol
• Synonyms: 3-Amino-4-fluorophenol;6004 3-AMINO-4-FLUORO PHENOL;3-Amino-4-fluorophenol 99%;Phenol,3-aMino-4-fluoro-;2-Fluoro-5-hydroxyaniline
• CAS NO: 62257-16-3
• Molecular Formula: C₆H₆FNO
• Molecular Weight: 127.12
• EINECS: 1308068-626-2
• Product Categories: Phenol&Thiophenol&Mercaptan
• Mol File: 62257-16-3.mol
• Article Data: 16

Chemical Properties

• Melting Point: 141-143 °C
• Boiling Point: 269.3 °C at 760 mmHg
• Flash Point: 116.7 °C
• Appearance: /
• Density: 1.347 g/cm³
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 10.03±0.18(Predicted)
• CAS DataBase Reference: 3-Amino-4-fluorophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-4-fluorophenol(62257-16-3)
• EPA Substance Registry System: 3-Amino-4-fluorophenol(62257-16-3)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Hazardous Substances Data: 62257-16-3(Hazardous Substances Data)

Usage

General Description

3-Amino-4-fluorophenol is an organic chemical compound with the molecular formula C6H6FNO. It is an aromatic amine that consists of a phenol group substituted with an amino and a fluorine group. 3-Amino-4-fluorophenol is commonly used as an intermediate in the synthesis of pharmaceuticals, dyes, and other organic compounds. It is known for its reactivity and is often used in organic chemistry reactions to introduce the amino and fluorine functional groups into other molecules. In addition, 3-Amino-4-fluorophenol has potential applications in the development of new materials and chemical technologies. However, it is important to handle this compound with care as it may pose some health and environmental hazards.

Upstream product

• 84478-75-1 2-chloro-4-fluoro-5-nitrophenol 
• 2105-96-6 4-fluoro-3-nitrophenol 
• 75001-47-7 N-(5-amino-2-fluorophenyl)acetamide 
• 1228996-49-3 2-fluoro-5-hydroxy-N-(trifluoroacetyl)aniline 
• 1996-41-4 2-chloro-4-fluorophenol 
• 84478-88-6 2-chloro-4-fluoro-methoxycarbonyloxybenzene 
• 84478-89-7 2-chloro-4-fluoro-5-nitro-methoxycarbonyloxybenzene 
• 369-36-8 6-fluoro-3-nitroaniline 
• 454-07-9 N-(2-fluoro-5-nitrophenyl)acetamide 

Downstream Products

• 1020173-02-7 5-(3-amino-4-fluorophenoxy)picolinonitrile 
• 1020173-04-9 2-fluoro-5-(2-(methylthio)pyrimidin-4-yloxy)benzenamine 
• 1020173-08-3 2-fluoro-5-(6-(trifluoromethyl)pyridin-3-yloxy)benzenamine 
• 1020173-36-7 5-(4-(1-(4-methoxybenzyl)-1H-pyrazol-4-yl)pyrimidin-2-yloxy)-2-fluorobenzenamine 
• 143661-65-8 2-fluoro-5-cyclopentyloxyaniline 
• 97936-90-8 N-(2-fluoro-5-hydroxyphenyl)-3,4,5,6-tetrahydrophthalimide 
• 932708-75-3 2-(2,4-dichlorobenzyl)-N-(2-fluoro-5-hydroxyphenyl)-3-oxobutyramide 
• 932707-72-7 (3-amino-4-fluorophenoxy)acetic acid methyl ester 
• 932709-68-7 (S)-2-(3-amino-4-fluorophenoxy)propionic acid methyl ester 
• 1068159-17-0 4-ethyl-8-fluoro-3-(4-methanesulfonylbenzyl)-2-methylquinolin-5-ol 
• 1068159-19-2 2-ethyl-8-fluoro-3-(4-methanesulfonylbenzyl)-4-methylquinolin-5-ol 
• 1020172-92-2 5-(5-chloropyridin-3-yloxy)-2-fluoroaniline 
• 1092394-25-6 3-[(tert-butoxycarbonyl)amino]-4-fluorophenyl tert-butylcarbonate 
• 1005788-04-4 N-(2-fluoro-5-hydroxyphenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide 

Relevant articles and documents

POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES

The current invention provides urea derivatives, in particular compounds having the core structure heteroaryl-NH-CO-NH-aryl-O- heteroaryl, for use in treating, ameliorating, delaying, curing and/ or preventing a disease or condition associated with muscle cells and/or satellite cells, such as Duchenne muscular dystrophy, Becker muscular dystrophy, cachexia or sarcopenia.

SUBSTITUTED PYRIDOBENZODIAZEPINONE-DERIVATIVES AND USE THEREOF

The present application relates to novel (3-hydroxyphenyl)amino-substituted pyrido[2,3-b][1,5]benzodiazepin-5-one derivatives, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially of angiogenic disorders and hyperproliferative disorders in which neovascularization plays a role, for example ophthalmological disorders and cancers and tumours. Such treatments can be effected as monotherapy or else in combination with other medicaments or further therapeutic measures.

Fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques

The present invention relates to novel fluorinated 3,6-diaminoxanthene compounds derived from the basic structural formula (I) and to their uses as photostable fluorescent dyes, e.g. for immunostainings and spectroscopic and microscopic applications, in particular in conventional microscopy, stimulated emission depletion (STED) reversible saturable optically linear fluorescent transitions (RESOLFT) microscopy, and fluorescence correlation spectroscopy. The claimed compounds are also useful as molecular probes in various spectroscopic applications.